{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:19:09Z","timestamp":1791472749008,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaip.2023.07.012","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:29:41Z","timestamp":1689568181000},"page":"3463-3472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0737","authenticated-orcid":false,"given":"Toshiki","family":"Fukasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Urushihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.07.012_bib1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaip.2023.07.012_bib2","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance Database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.07.012_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2023.07.012_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib5","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2023.07.012_bib6","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/epi.13925","article-title":"The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs","volume":"58","author":"Frey","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2023.07.012_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jid.2017.12.015","article-title":"Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study","volume":"138","author":"Frey","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40264-018-0711-x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in association with commonly prescribed drugs in outpatient care other than anti-epileptic drugs and antibiotics: a population-based case-control study","volume":"42","author":"Frey","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2023.07.012_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/epi.16751","article-title":"Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: a nationwide study using health claims data in Korea","volume":"62","author":"Chung","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2023.07.012_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221130","article-title":"Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan","volume":"14","author":"Fukasawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.07.012_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.alit.2021.01.004","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: matched case-control and cohort studies","volume":"70","author":"Fukasawa","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2023.07.012_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.07.012_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/all.14174","article-title":"Genetic variants associated with T-cell-mediated cutaneous adverse drug reactions: a PRISMA-compliant systematic review\u2014an EAACI position paper","volume":"75","author":"Oussalah","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.07.012_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt.1071","article-title":"The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA label","volume":"105","author":"Wang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.07.012_bib16","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jid.2019.12.025","article-title":"Association of HLA-A\u221711:01 with sulfonamide-related severe cutaneous adverse reactions in Japanese patients","volume":"140","author":"Nakamura","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.07.012_bib18","article-title":"Genomic risk factors driving immune-mediated delayed drug hypersensitivity reactions","volume":"12","author":"Li","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jaip.2023.07.012_bib19","first-page":"118","article-title":"Data resource profile: JMDC claims database sourced from health insurance societies","volume":"22","author":"Nagai","year":"2021","journal-title":"J\u00a0Gen Fam Med"},{"key":"10.1016\/j.jaip.2023.07.012_bib20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2183\/pjab.98.026","article-title":"Clinical epidemiology and pharmacoepidemiology studies with real-world databases","volume":"98","author":"Yoshida","year":"2022","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.jaip.2023.07.012_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CORR.0000000000002322","article-title":"Reoperation rates of microendoscopic discectomy compared with conventional open lumbar discectomy: a large-database study","volume":"481","author":"Masuda","year":"2023","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jaip.2023.07.012_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2023.07.012_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0962280208092346","article-title":"The case-crossover study design in pharmacoepidemiology","volume":"18","author":"Delaney","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jaip.2023.07.012_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/clpt.2010.74","article-title":"Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide","volume":"88","author":"Schelleman","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.07.012_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pds.3846","article-title":"The risk of acute liver injury among users of antibiotic medications: a comparison of case\u2014only studies","volume":"25","author":"Brauer","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2023.07.012_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a117550","article-title":"Control sampling strategies for case-crossover studies: an assessment of relative efficiency","volume":"142","author":"Mittleman","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2023.07.012_bib29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ije\/dyu081","article-title":"Exchangeability in the case-crossover design","volume":"43","author":"Mittleman","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaip.2023.07.012_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.07.012_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2023.07.012_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/all.12410","article-title":"The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome","volume":"69","author":"Ishida","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.07.012_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: an\u00a0observational, retrospective case series study","volume":"13","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib34","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1002\/sim.2687","article-title":"A\u00a0comparative investigation of methods for logistic regression with separated or nearly separated data","volume":"25","author":"Heinze","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.jaip.2023.07.012_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/oxfordjournals.aje.a010240","article-title":"Problems due to small samples and sparse data in conditional logistic regression analysis","volume":"151","author":"Greenland","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2023.07.012_bib36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/sim.3794","article-title":"Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets","volume":"29","author":"Heinze","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jaip.2023.07.012_bib37","author":"Heinze"},{"key":"10.1016\/j.jaip.2023.07.012_bib38","first-page":"2467","article-title":"Epidemiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis throughout Japan","volume":"121","author":"Kitami","year":"2011","journal-title":"Jpn J Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jac\/dky445","article-title":"Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study","volume":"74","author":"Kang","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2023.07.012_bib40","doi-asserted-by":"crossref","first-page":"S637","DOI":"10.1067\/mai.2000.106156","article-title":"Understanding drug allergies","volume":"105","author":"Gruchalla","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.07.012_bib41","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.07.012_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdin.2022.12.002","article-title":"Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database","volume":"11","author":"Ubukata","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaip.2023.07.012_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2023.07.012_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaip.2023.07.012_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2230.2004.01649.x","article-title":"Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"29","author":"Waldman","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jcpt.12159","article-title":"Stevens-Johnson syndrome induced by the cross-reactivity between teicoplanin and vancomycin","volume":"39","author":"Yang","year":"2014","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jaip.2023.07.012_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fped.2018.00026","article-title":"Vancomycin-induced Stevens-Johnson syndrome in a boy under 2 years old: an early diagnosis by granulysin rapid test","volume":"6","author":"Lin","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2023.07.012_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaip.2020.09.011","article-title":"A\u00a0nationwide study of severe cutaneous adverse reactions based on the multicenter registry in Korea","volume":"9","author":"Kang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.07.012_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.872854","article-title":"Stevens-Johnson syndrome following vancomycin and linezolid: a real-world analysis of post-marketing surveillance data","volume":"13","author":"Ni","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2023.07.012_bib50","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pds.1438","article-title":"\u201cWhy me?\u201d versus \u201cwhy now?\u201d\u2014differences between operational hypotheses in case-control versus case-crossover studies","volume":"16","author":"Maclure","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2023.07.012_bib51","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaip.2019.11.035","article-title":"Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: a retrospective population-based study","volume":"8","author":"Liang","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.07.012_bib52","first-page":"1637","article-title":"Japanese clinical guidelines for Stevens-Johnson syndrome and toxic epidermal necrolysis [in Japanese]","volume":"126","year":"2016","journal-title":"Jpn J Dermatol"},{"key":"10.1016\/j.jaip.2023.07.012_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jdcr.2017.03.005","article-title":"Multiple drug sensitization syndrome: a distinct phenotype associated with unrecognized Mycoplasma pneumonia infection","volume":"3","author":"Aoyama","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2023.07.012_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","article-title":"A\u00a0complex interaction between drug allergy and viral infection","volume":"33","author":"Shiohara","year":"2007","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823007833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823007833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:39:07Z","timestamp":1761975547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823007833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213219823007833"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.07.012","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}